Therapeutic Sequencing in ALK(+) NSCLC

Elsayed, M; Christopoulos, P

Christopoulos, P (corresponding author), Heidelberg Univ Hosp, Dept Thorac Oncol, Thoraxklin, D-69126 Heidelberg, Germany.; Christopoulos, P (corresponding author), Heidelberg Univ Hosp, Natl Ctr Tumor Dis NCT, D-69126 Heidelberg, Germany.; Christopoulos, P (corresponding author), Translat Lung Res Ctr Heidelberg TLRC H, D-69126 Heidelberg, Germany.; Christopoulos, P (corresponding author), German Ctr Lung Res DZL, D-69126 Heidelberg, Germany.

PHARMACEUTICALS, 2021; 14 (2):

Abstract

Anaplastic lymphoma kinase-rearranged non-small-cell lung cancer (ALK(+) NSCLC) is a model disease for the use of targeted pharmaceuticals in thoracic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索